38 related articles for article (PubMed ID: 17868394)
1. High-dose intravenous immunoglobulin co-treatment prolongs time-to-treatment escalation in autoimmune bullous diseases: A monocentric retrospective cohort study.
Bertlich M; Bertlich I; Plümacher N; Hadaschik E; Enk A; Hoffmann JHO
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e74-e76. PubMed ID: 37595621
[No Abstract] [Full Text] [Related]
2. Management Options for Linear Immunoglobulin A (IgA) Bullous Dermatosis: A Literature Review.
Khan M; Park L; Skopit S
Cureus; 2023 Mar; 15(3):e36481. PubMed ID: 37090290
[TBL] [Abstract][Full Text] [Related]
3. Treatment of subepidermal immunobullous diseases.
Culton DA; Diaz LA
Clin Dermatol; 2012; 30(1):95-102. PubMed ID: 22137232
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.
Talhari C; Mahnke N; Ruzicka T; Megahed M
Clin Exp Dermatol; 2005 May; 30(3):297-8. PubMed ID: 15807696
[No Abstract] [Full Text] [Related]
5. Successful treatment of linear IgA bullous dermatosis with mycophenolate mofetil.
Gläser R; Sticherlin M
Acta Derm Venereol; 2002; 82(4):308-9. PubMed ID: 12361143
[No Abstract] [Full Text] [Related]
6. Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil.
Farley-Li J; Mancini AJ
Arch Dermatol; 2003 Sep; 139(9):1121-4. PubMed ID: 12975151
[No Abstract] [Full Text] [Related]
7. Linear IgA bullous dermatosis responsive to trimethoprim-sulfamethoxazole.
Peterson JD; Chan LS
Clin Exp Dermatol; 2007 Nov; 32(6):756-8. PubMed ID: 17868394
[No Abstract] [Full Text] [Related]
8. [Linear IgA bullous dermatosis: a review].
Ingen-Housz-Oro S
Ann Dermatol Venereol; 2011 Mar; 138(3):214-20. PubMed ID: 21397151
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for the management of autoimmune bullous diseases.
Eskin-Schwartz M; David M; Mimouni D
Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil for the management of autoimmune bullous diseases.
Eskin-Schwartz M; David M; Mimouni D
Immunol Allergy Clin North Am; 2012 May; 32(2):309-15, vii. PubMed ID: 22560143
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
